NO20032160D0 - Supplement for enteral administrering for parenteral ern¶ring eller parenteral/oral ern¶ring av kritisk syke, kronisk syke og mangelfulltern¶rte - Google Patents

Supplement for enteral administrering for parenteral ern¶ring eller parenteral/oral ern¶ring av kritisk syke, kronisk syke og mangelfulltern¶rte

Info

Publication number
NO20032160D0
NO20032160D0 NO20032160A NO20032160A NO20032160D0 NO 20032160 D0 NO20032160 D0 NO 20032160D0 NO 20032160 A NO20032160 A NO 20032160A NO 20032160 A NO20032160 A NO 20032160A NO 20032160 D0 NO20032160 D0 NO 20032160D0
Authority
NO
Norway
Prior art keywords
parenteral
nutrition
ill
supplement
malnourished
Prior art date
Application number
NO20032160A
Other languages
English (en)
Other versions
NO333003B1 (no
NO20032160L (no
Inventor
Barbara Kessler
Angelika Riedel
Ulrich Suchner
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Publication of NO20032160D0 publication Critical patent/NO20032160D0/no
Publication of NO20032160L publication Critical patent/NO20032160L/no
Publication of NO333003B1 publication Critical patent/NO333003B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20032160A 2000-11-17 2003-05-13 Supplement for enteral administrering for parenteral ernaering eller partial enteral/oral ernaering av kritiske syke, kronisk syke eller mangelfullt ernaerte samt anvendelse av komponentene for fremstilling derav NO333003B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10057290A DE10057290B4 (de) 2000-11-17 2000-11-17 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
PCT/EP2001/013163 WO2002039978A1 (de) 2000-11-17 2001-11-14 Enteral zu verabreichendes supplement zur parenteralen ernährung oder partiellen enteralen/oralen ernährung bei kritisch kranken, chronisch kranken und mangelernährten

Publications (3)

Publication Number Publication Date
NO20032160D0 true NO20032160D0 (no) 2003-05-13
NO20032160L NO20032160L (no) 2003-07-14
NO333003B1 NO333003B1 (no) 2013-02-11

Family

ID=7663817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032160A NO333003B1 (no) 2000-11-17 2003-05-13 Supplement for enteral administrering for parenteral ernaering eller partial enteral/oral ernaering av kritiske syke, kronisk syke eller mangelfullt ernaerte samt anvendelse av komponentene for fremstilling derav

Country Status (28)

Country Link
US (1) US7947303B2 (no)
EP (1) EP1337236B1 (no)
JP (1) JP2004513912A (no)
KR (2) KR20080069280A (no)
CN (1) CN1477950A (no)
AT (1) ATE272390T1 (no)
AU (2) AU2484802A (no)
BR (1) BRPI0115451B1 (no)
CA (1) CA2429270C (no)
CZ (1) CZ300129B6 (no)
DE (2) DE10057290B4 (no)
DK (1) DK1337236T3 (no)
EE (1) EE05209B1 (no)
ES (1) ES2223015T3 (no)
HR (1) HRP20030395B1 (no)
HU (1) HU228351B1 (no)
IL (2) IL155840A0 (no)
IS (1) IS2377B (no)
MX (1) MXPA03004348A (no)
NO (1) NO333003B1 (no)
NZ (1) NZ525812A (no)
PL (1) PL202031B1 (no)
PT (1) PT1337236E (no)
RU (1) RU2295952C2 (no)
SI (1) SI1337236T1 (no)
SK (1) SK286199B6 (no)
WO (1) WO2002039978A1 (no)
ZA (1) ZA200303722B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
US20070026090A1 (en) * 2003-09-05 2007-02-01 Oren Tirosh Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
JP2007505899A (ja) * 2003-09-19 2007-03-15 エヌ．ブイ．・ヌートリシア 多臓器機能不全を予防するための方法及び組成物
DE10349585A1 (de) 2003-10-24 2005-06-16 Biosyn Arzneimittel Gmbh Spurenelementzusammensetzung für die Ernährung
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use
CA2586936C (en) * 2004-11-09 2019-08-20 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
CA2588911C (en) * 2004-12-21 2013-04-23 Critical Care Connections, Inc. Therapeutic nutrient compositions or combinations and methods of their use
EP2258219B2 (en) * 2005-04-27 2022-07-20 N.V. Nutricia Nutrition with lipids and non-digestible saccharides
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
WO2006127695A2 (en) * 2005-05-23 2006-11-30 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Ascorbic acid conjugates
US20090220637A1 (en) * 2005-08-26 2009-09-03 Nestec S.A. Nutrition for obese patients
DE102005046237A1 (de) * 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
CN101843609A (zh) * 2005-11-15 2010-09-29 安特瑞斯公司 用于与软骨损伤有关的应用的药物
AU2007204347B2 (en) * 2006-01-09 2012-05-17 Nestec S.A. Treatment of stressed patients
EP2032170B1 (en) * 2006-06-14 2012-11-28 N.V. Nutricia Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
KR100774816B1 (ko) * 2006-11-21 2007-11-07 동부일렉트로닉스 주식회사 반도체 소자의 ｍｉｍ 커패시터 제조 방법 및 구조
EP3263120A1 (en) * 2007-09-17 2018-01-03 N.V. Nutricia Nutritional formulation with high energy content
MX2010004110A (es) * 2007-10-14 2010-07-28 Univ Florida Formulacion para mejorar la funcion gastrointestinal.
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
JP2013529193A (ja) * 2010-04-26 2013-07-18 ネステク ソシエテ アノニム 非経口栄養から経腸栄養へ離脱させるための栄養組成物及び方法
EP2691089A1 (en) * 2011-03-31 2014-02-05 Nestec S.A. Nutritional compositions for increasing arginine levels and methods of using same
KR102100091B1 (ko) 2011-04-13 2020-04-14 아지노모토 가부시키가이샤 영양 조성물
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
WO2016199798A1 (ja) 2015-06-10 2016-12-15 味の素株式会社 運動誘発性の消化管障害の改善剤
ES2638195B1 (es) 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
CN116779143A (zh) 2017-05-09 2023-09-19 巴克斯特国际公司 胃肠外营养诊断***、设备和方法
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation
DE202021102589U1 (de) 2020-12-15 2021-05-28 Marco Lautenschläger Verzehrfertiges, abgefülltes Getränk auf Basis eines natürlichen Mineralwassers
WO2023205635A1 (en) * 2022-04-19 2023-10-26 Vanderbilt University Compositions and methods of treatment for congenital diarrheal disorder
WO2023215458A1 (en) * 2022-05-06 2023-11-09 Ageless Sciences, Inc. Compositions and methods for slowing down aging and extending lifespan
CN116920075B (zh) * 2023-09-15 2024-01-02 潍坊市人民医院(潍坊市公共卫生临床中心) 一种肠内营养液及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
DE3135849A1 (de) * 1981-09-10 1983-03-17 Dr. Schumacher GmbH & Co KG, 4600 Dortmund Beschichtungsstoff fuer korrosionsschutzzwecke
US4446389A (en) * 1982-03-15 1984-05-01 Ampex Corporation Quadrature tach decoder circuit
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JP2524551B2 (ja) * 1992-02-28 1996-08-14 雪印乳業株式会社 グルタミン含量の高いペプチド組成物、その製造方法及び経腸栄養剤
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
WO1994014458A1 (en) 1992-12-23 1994-07-07 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
JP4059532B2 (ja) * 1994-08-15 2008-03-12 森永乳業株式会社 腸内細菌の体内移行を阻止するペプチド混合物と、このペプチド混合物を含有する組成物
US5719133A (en) 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP4011638B2 (ja) * 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH09323979A (ja) * 1996-06-04 1997-12-16 Meiji Milk Prod Co Ltd 核酸を用いた免疫調節組成物
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
WO1998041216A1 (en) * 1997-03-17 1998-09-24 Tam Yun K Composition for prevention of hepatic steatosis
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AU2186699A (en) * 1998-02-09 1999-08-23 Meiji Milk Products Co., Ltd. Preventives and remedies for intestinal mucosal disorder
US6369252B1 (en) * 1998-02-26 2002-04-09 The University Of Georgia Research Foundation, Inc. Structured lipids
WO2000015043A1 (en) * 1998-09-11 2000-03-23 Danisco Cultor America, Inc. Reduced calorie plastic fat composition
JP2000119180A (ja) * 1998-10-06 2000-04-25 Nisshin Flour Milling Co Ltd 経腸栄養剤
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives

Also Published As

Publication number Publication date
BR0115451A (pt) 2004-01-06
ZA200303722B (en) 2004-04-16
EP1337236B1 (de) 2004-08-04
RU2295952C2 (ru) 2007-03-27
AU2484802A (en) 2002-05-27
IS2377B (is) 2008-07-15
NO333003B1 (no) 2013-02-11
BRPI0115451B1 (pt) 2016-07-19
EE05209B1 (et) 2009-10-15
HUP0301386A3 (en) 2008-04-28
ATE272390T1 (de) 2004-08-15
NZ525812A (en) 2004-03-26
CZ300129B6 (cs) 2009-02-18
IL155840A (en) 2008-11-03
SK5612003A3 (en) 2003-10-07
HRP20030395B1 (en) 2011-10-31
CA2429270C (en) 2009-08-18
IS6815A (is) 2003-05-14
WO2002039978A1 (de) 2002-05-23
ES2223015T3 (es) 2005-02-16
HU228351B1 (hu) 2013-03-28
DE10057290B4 (de) 2004-01-08
CN1477950A (zh) 2004-02-25
CA2429270A1 (en) 2002-05-23
US20040097404A1 (en) 2004-05-20
NO20032160L (no) 2003-07-14
US7947303B2 (en) 2011-05-24
JP2004513912A (ja) 2004-05-13
PT1337236E (pt) 2004-11-30
WO2002039978A8 (de) 2002-07-18
SI1337236T1 (en) 2004-12-31
HRP20030395A2 (en) 2005-04-30
DK1337236T3 (da) 2004-12-13
DE50103152D1 (de) 2004-09-09
KR20030069172A (ko) 2003-08-25
KR100861889B1 (ko) 2008-10-09
AU2002224848B2 (en) 2006-06-15
DE10057290A1 (de) 2002-06-06
EP1337236A1 (de) 2003-08-27
PL361634A1 (en) 2004-10-04
EE200300198A (et) 2003-08-15
MXPA03004348A (es) 2003-08-19
SK286199B6 (sk) 2008-05-06
HUP0301386A2 (hu) 2003-09-29
CZ20031337A3 (cs) 2003-09-17
KR20080069280A (ko) 2008-07-25
IL155840A0 (en) 2003-12-23
PL202031B1 (pl) 2009-05-29

Similar Documents

Publication Publication Date Title
NO20032160D0 (no) Supplement for enteral administrering for parenteral ern¶ring eller parenteral/oral ern¶ring av kritisk syke, kronisk syke og mangelfulltern¶rte
AU2002224848A1 (en) Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
NZ508142A (en) Treatment of iatrogenic and age-related hypertension with vitamin B6 or derivatives thereof
IL135335A0 (en) Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids
AR054257A1 (es) Suplemento nutricional para pacientes con hiv
IT1312377B1 (it) Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
MX9205722A (es) Composicion alimenticia enteral contra el cancer
Kulkarni et al. L-Glutamic acid and glutamine: Exciting molecules of clinical interest
IS2234B (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
ATE92756T1 (de) Mittel zur behandlung von keratose.
ATE217494T1 (de) Orale darreichungsform
ES2163419T3 (es) Composiciones nutritivas para el tratamiento del metabolismo del nitrogeno.
DK1208078T3 (da) Ikke-hygroskopiske salte af aktive bestanddele der har terapeutiske og/eller ernæringsmæssige aktiveteter og sammensætninger til oral indgivelse der indeholder disse
Iida Experimental studies on the craving for alcohol: II. Alcoholic drive in mice following administration of hepatotoxic agents
Maladkar et al. Essential Immunonutrients in COVID-19: An Evidence-Based Review.
RU2012156681A (ru) Средство (варианты), фармацевтическая композиция и способ химиопрофилактики предрака и рака предстательной железы
Vaisrub An element of pleasure
GB1327469A (en) Pharmaceutical compositions for inhibiting indoleamine n-methyl transferase
Muto et al. Influence of Feeding Milk Diet or Soy Diet on the Serum Cholesterol Level of the Growing Animal
Bürger et al. Prospective study on the outcome of nutritional therapy including formula diets in malnourished HIV-infected
RU98119423A (ru) Способ лечения дисбактериозов кишечника у детей и взрослых
Plata-Salaman et al. Endogenous sugar acid acting as a feeding suppressant
RU99125353A (ru) Способ моделирования угнетения гармональной активности яичников

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees